ПЕРАМПАНЕЛ: ФАРМАКОКИНЕТИКА И ЛЕКАРСТВЕННЫЕ ВЗАИМОДЕЙСТВИЯ
References
1. Fuseau E., Templeton D., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel in Patients with Refractory Partial Seizures. Epilepsy Currents. 2011; 11 (1): Abs 1.264.
2. Hussein Z., Critchley D., Ferry J., Laurenza A. Population Pharmacokinetics of Perampanel, a Selective, Non-competitive AMPA Receptor Antagonist, in Patients with Refractory Partial Onset Seizures Participating in a Randomized, Double-blind, Placebo-controlled Phase III Study. Epilepsia. 2011; 52 (6): 248-9.
3. Laurenza A., Ferry J., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel: APooled Analysis From Three Phase III Trials. Epilepsy Currents. 2012; 12 (1): 216-7.
4. Patsalos P.N. Drug Interactions With the Newer Antiepileptic Drugs (AEDs) – Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs. Clinical Pharmacokinetics. 2013a; 52: 927-966.
5. Patsalos P.N. Drug Interactions with the Newer antiepileptic drugs (AEDs) – Part 2: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs and Drugs Used to Treat Non-epilepsy Disorders. Clinical Pharmacokinetics. 2013b; 52: 1045-1061.
6. Инструкция по медицинскому применению прапарата Файкомпа РУ ЛП 002200 от 23.08.2013.
Review
For citations:
. . Epilepsy and paroxysmal conditions. 2014;6(5):16-18. (In Russ.)
Views: 460
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
